Health and Fitness Health and Fitness
Tue, September 14, 2010
[ Tue, Sep 14th 2010 ] - Market Wire
Law Offices of Howard G. Smith Announces Investig .. lf of Shareholders of Acura Pharmaceuticals, Inc.
[ Tue, Sep 14th 2010 ] - Market Wire
Law Offices of Howard G. Smith Announces Investig .. n On Behalf of Shareholders of ZymoGenetics, Inc.
[ Tue, Sep 14th 2010 ] - Market Wire
Micrus Announces Stockholder Approval of Merger Agreement with Johnson & Johnson
[ Tue, Sep 14th 2010 ] - Market Wire
Laboratory Corporation of America Holdings, Genzy .. ger Company, Wal-Mart Stores and Costco Wholesale
[ Tue, Sep 14th 2010 ] - Market Wire
Celera to Webcast Its Presentation at the UBS Global Life Sciences Conference
[ Tue, Sep 14th 2010 ] - Market Wire
NPS Pharmaceuticals to Present at UBS Global Life Sciences Conference
[ Tue, Sep 14th 2010 ] - Market Wire
Alnylam to Webcast Presentation at UBS Global Life Sciences Conference
[ Tue, Sep 14th 2010 ] - Market Wire
Human Genome Sciences Invites Investors to Listen .. entation at Stifel Nicolaus Healthcare Conference
[ Tue, Sep 14th 2010 ] - Market Wire
Law Office of Jonathan M. Stein, P.L. Investigate .. ary Duty by the Officers and Directors of Acura P
[ Tue, Sep 14th 2010 ] - Market Wire
Medtronic CFO Gary Ellis to Speak at UBS Global Life Sciences Conference
[ Tue, Sep 14th 2010 ] - Market Wire
American Medical Systems Receives Favorable Ruling in Patent Lawsuit against Biolitec
[ Tue, Sep 14th 2010 ] - Market Wire
Synergy Pharmaceuticals participa en el Simposio Roche Colorado Corporation Peptide 2010
[ Tue, Sep 14th 2010 ] - Market Wire
Aetna Wins Contract for Illinois Managed Medicaid Pilot Program
[ Tue, Sep 14th 2010 ] - Market Wire
The Briscoe Law Firm and Powers Taylor, LLP Inves .. Fiduciary Duties by the Officers and Directors of
[ Tue, Sep 14th 2010 ] - Market Wire
El tratamiento VIH de nico comprimido "Quad" de G .. in viral durante 48 semanas en estudio de fase II
[ Tue, Sep 14th 2010 ] - Market Wire
Genmab and Seattle Genetics Enter into Antibody-Drug Conjugate Research Collaboration
[ Tue, Sep 14th 2010 ] - Market Wire
Alexion to Present at the UBS Global Life Sciences Conference
[ Tue, Sep 14th 2010 ] - Market Wire
Alkermes Announces Posting of Briefing Documents .. ttee Meeting for VIVITROL® for Opioid Dependence
[ Tue, Sep 14th 2010 ] - Market Wire
Guided Therapeutics Completes $3 Million Financing
[ Tue, Sep 14th 2010 ] - Market Wire
Somaxon Pharmaceuticals to Present at the UBS Global Life Sciences Conference
[ Tue, Sep 14th 2010 ] - Market Wire
Unigene CEO Presents New Strategy and Corporate R .. odman & Renshaw 12th Annual Healthcare Conference
[ Tue, Sep 14th 2010 ] - Market Wire
Derma Sciences to Complete Enrollment in DSC127 Phase 2 Wound Healing Trial This Month
[ Tue, Sep 14th 2010 ] - Market Wire
Synergy Pharmaceuticals interverr al Roche Colorado Corporation Peptide Symposium 2010
[ Tue, Sep 14th 2010 ] - Market Wire
Vortrag von Synergy Pharmaceuticals auf dem Roche Colorado Corporation Peptide Symposium 2010
[ Tue, Sep 14th 2010 ] - Market Wire
Synergy Pharmaceuticals effectuera une pr©sentat .. 10 de Roche Colorado Corporation sur les peptides
[ Tue, Sep 14th 2010 ] - Market Wire
Synergy Pharmaceuticals aanwezig op Roche Colorado Corporation Peptide Symposium 2010
[ Tue, Sep 14th 2010 ] - Market Wire
Synergy Pharmaceuticals to Present at Roche Colorado Corporation Peptide Symposium 2010
[ Tue, Sep 14th 2010 ] - Market Wire
Zalicus To Present at the Rodman & Renshaw Annual Global Investment Conference NYC
[ Tue, Sep 14th 2010 ] - Market Wire
CENTRIC HEALTH APPOINTS DR. PAUL GAMBLE TO BOARD OF DIRECTORS
[ Tue, Sep 14th 2010 ] - Market Wire
Inspire Announces Webcasts of Presentations at th .. nference and the JMP Securities Healthcare Confer

Inspire Announces Webcasts of Presentations at the UBS Global Life Sciences Conference and the JMP Securities Healthcare Confer


Published on 2010-09-14 03:40:59 - Market Wire
  Print publication without navigation


DURHAM, N.C.--([ BUSINESS WIRE ])--Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) announced today that Adrian Adams, President and CEO, will present at the UBS Global Life Sciences Conference on Tuesday, September 21, 2010 at 9:00 am ET and at the JMP Securities Healthcare Conference on Monday, September 27, 2010 at 12:00 pm ET in New York City.

The webcasts of the presentations will be available on Inspirea™s website at [ www.inspirepharm.com ]. Archived versions of the webcast presentations will also be available through this link for a limited time following the conference.

About Inspire

Inspire is a biopharmaceutical company focused on researching, developing and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases. Inspirea™s goal is to build and commercialize a sustainable portfolio of innovative new products based on its technical, scientific and commercial expertise. Inspirea™s clinical pipeline includes denufosol tetrasodium for cystic fibrosis in Phase 3 development and AZASITE®(azithromycin ophthalmic solution) 1% for blepharitis in Phase 2 development. Inspire receives revenues related to the promotion of AZASITE for bacterial conjunctivitis, the co-promotion of ELESTAT® (epinastine HCl ophthalmic solution) 0.05% for allergic conjunctivitis and royalties based on net sales of RESTASIS® (cyclosporine ophthalmic emulsion) 0.05% for dry eye. For more information, visit [ www.inspirepharm.com ].

Contributing Sources